BNT Basepoint

RNS Number:2500T
Basepoint PLC
27 October 2005


Basepoint plc ("Basepoint" or "the Company")


Exercise of Options


Basepoint was notified today that certain employees of the Company, including
Philip Stansfield who is a director of the Company, exercised options over
41,000 ordinary shares of 10p each under the Basepoint plc Approved Share Option
Scheme.


Details of the options exercised are as follows:

Optionholder                          Exercise Price       Number of
                                           per Share         Options
                                                           Exercised
P A Stansfield                                 60.0p           2,000
P A Stansfield                                 63.5p           6,000
Other employees                                63.5p           7,000
P A Stansfield                                 86.5p           3,000
Other employees                                86.5p           6,000
Other employees                                93.5p          17,000


Following the exercise of his options, Mr Stansfield's current beneficial
shareholding in the Company amounts to 17,000 ordinary shares, representing 0.15
per cent. of the issued share capital of Basepoint.


An application has been made for the 41,000 new ordinary shares to be admitted
to AIM and trading is expected to commence on 2 November 2005.


The Company is required to disclose the following information in accordance with
Rule 2.10 of the City Code on Takeovers and Mergers:


Following the exercise of the options, the Company has 11,255,588 ordinary
shares of 10p each in issue. The International Securities Identification Number
(ISIN) for the ordinary shares is GB0007381295.


27 October 2005







                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
IOEPUGGUUUPAGPM

Basepoint (LSE:BNT)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024

Basepoint (LSE:BNT)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024